??? ??? ???? / JAK / STAT

JAK ??? STAT ??? ? ???

?? ??? ???? ??? ?? ??, ??, ?? ??? ???.

?? ??	CAS	MF
Tofacitinib	477600-75-2	C16H20N6O
N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide	936091-14-4	C26H35N7O2S
Fedratinib	936091-26-8	C27H36N6O3S
LY 2784544	1229236-86-5	C23H25ClFN7O
XL019	945755-56-6	C25H28N6O2
AZD 1480	935666-88-9	C14H14ClFN8
AT9283	896466-04-9	C19H23N7O2
Baricitinib	1187594-09-7	C16H17N7O2S
(5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione	438190-29-5	C11H6F3NO2S
AZD-1208	1204144-28-4	C21H21N3O2S
SGI-1776	1025065-69-3	C20H22F3N5O
S3I-201	501919-59-1	C16H15NO7S
Stattic	19983-44-9	C8H5NO4S
?????	937272-79-2	C28H32N4O3
JAK3 Inhibitor	211555-04-3	C16H14BrN3O3
WP1066	857064-38-1	C17H14BrN3O
GLPG0634	1206101-20-3	C23H18N6O2
Filgotinib	1206161-97-8	C21H23N5O3S
HO-3867	1172133-28-6	C28H30F2N2O2
CEP 33779	1257704-57-6	C24H26N6O2S
Cerdulatinib HCl salt	1369761-01-2	C20H28ClN7O3S
ZM 39923 HCl	1021868-92-7	C23H26ClNO
CX6258(HCL)	1353859-00-3	C26H25Cl2N3O3
S-?????(INCB018424)	941685-37-6	C17H18N6
SH-4-54	1456632-40-8	C29H27F5N2O5S